Highlights and Quick Summary
- Retained Earnings for the quarter ending February 28, 2023 was $-216 Million (a 2.47% increase compared to previous quarter)
- Year-over-year quarterly Retained Earnings decreased by -3.09%
- Annual Retained Earnings for 2022 was $-228 Million (a 4.85% increase from previous year)
- Annual Retained Earnings for 2021 was $-217 Million (a 101.63% increase from previous year)
- Annual Retained Earnings for 2020 was $-108 Million (a 1527.49% increase from previous year)
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Retained Earnings of Organigram Holdings Inc.
Most recent Retained Earningsof OGI including historical data for past 10 years.Interactive Chart of Retained Earnings of Organigram Holdings Inc.
Organigram Holdings Inc. Retained Earnings for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $-216.44 | – | – | – | – |
| 2022 | $-211.23 | $-227.94 | $-223.34 | $-221.0 | $-227.94 |
| 2021 | $-220.48 | $-217.4 | $-199.19 | $-192.75 | $-217.4 |
| 2020 | $-136.16 | $-107.82 | $-76.1 | $-12.51 | $-107.82 |
| 2019 | $-7.3 | $-6.63 | $10.2 | $17.9 | $-6.63 |
| 2018 | – | – | $23.11 | $0.59 | $0.59 |
| 2017 | – | – | – | – | $-15.56 |
| 2016 | – | – | – | – | $-6.77 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic